Compare ARQT & ANDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARQT | ANDE |
|---|---|---|
| Founded | 2016 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Farming/Seeds/Milling |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.6B |
| IPO Year | 2020 | 2005 |
| Metric | ARQT | ANDE |
|---|---|---|
| Price | $27.41 | $70.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | $34.00 | ★ $75.00 |
| AVG Volume (30 Days) | ★ 1.7M | 266.2K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.03% |
| EPS Growth | ★ 88.79 | 12.93 |
| EPS | N/A | ★ 0.97 |
| Revenue | $376,072,000.00 | ★ $11,008,928,000.00 |
| Revenue This Year | $34.85 | $7.28 |
| Revenue Next Year | $29.39 | $3.57 |
| P/E Ratio | ★ N/A | $72.97 |
| Revenue Growth | ★ 91.34 | N/A |
| 52 Week Low | $13.06 | $31.84 |
| 52 Week High | $31.77 | $82.11 |
| Indicator | ARQT | ANDE |
|---|---|---|
| Relative Strength Index (RSI) | 73.65 | 44.77 |
| Support Level | $24.81 | $69.23 |
| Resistance Level | $28.80 | $70.06 |
| Average True Range (ATR) | 1.20 | 2.18 |
| MACD | 0.46 | -0.12 |
| Stochastic Oscillator | 88.31 | 35.50 |
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
Andersons Inc is an agriculture and renewable fuels company. Its operations are classified into two reportable business segments: Agribusiness, which generates maximum revenue, and Renewables. The Agribusiness segment includes merchandising and managing logistics across various commodities, as well as being a manufacturer, distributor, and retailer of agricultural and related plant nutrients. The segment specializes in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. The Renewables segment mainly produces, purchases, and sells ethanol and co-products. Geographically, the company generates maximum revenue from the United States, followed by Canada, Mexico, and other markets.